The Asia Pacific Cell Therapy Market would witness market growth of 28.6% CAGR during the forecast period (2020-2026). The increasing number of clinical studies for cell-based therapies is boosting the growth of the market. This has brought considerable global funding in R&D and their clinical translation.
The rising number of ongoing clinical trials is the result of the existence of government and private funding agencies that are consistently providing investments to promote projects across several phases of clinical trials.
In addition, the gradual advent of the latest technologies to encourage the growth of advanced therapies has fuelled the growth of the market. The arrival of proprietary cell lines is regarded as the main medium by which a product can be used for the manufacturing of a robust portfolio of candidates. For instance, Immunicum employs Chimeric Antigen Receptor T cell (CAR-T) expansion, T-cell primers, and dendritic cell neoantigen presentation technology to promote their product offerings for immuno-oncology.
Precision medicine can be considered as a new method for disease treatment and prevention, which considers individual variability in genes, environments, and lifestyles. Precision medicine includes the selection of drugs completely suitable to a patient on the basis of disease condition and history. Though this practice is expanding into all disease regions, oncology has witnessed the most development. Precision medicine provides a new pattern in oncology, where a patient gets personalized treatment. This method to disease diagnosis, treatment, prevention uses a global view of patients – from their genes and their environment to their lifestyles, like CAR-T therapy, are some of the major development.
The China market dominated the Asia Pacific Hospitals & Clinics Market by Country 2019, growing at a CAGR of 27.8 % during the forecast period. The Japan market is showcasing a CAGR of 29.5% during (2020 - 2026). Additionally, The India market is poised to grow at a CAGR of 31% during (2020 - 2026).
The Stem Cell market dominated the Malaysia Cell Therapy Market by Cell Type 2019, thereby, achieving a market value of $118.1 million by 2026. The Umbilical Cord-Derived market is estimated to grow at a CAGR of 32.7% during (2020 - 2026). The Adipose-Derived Stem Cell market is experiencing a CAGR of 34.1% during (2020 - 2026). Additionally, The Non-Stem Cell market is expected to witness a CAGR of 33.3% during (2020 - 2026).
Based on Therapy Type, the market is segmented into Autologous and Allogeneic. Based on Therapeutic Area, the market is segmented into Malignancies, Autoimmune Disorders, Musculoskeletal Disorders, Dermatology and Others. Based on End User, the market is segmented into Academic & Research Institutes and Hospitals & Clinics. Based on Cell Type, the market is segmented into Stem Cell, Umbilical Cord-Derived, Adipose-Derived Stem Cell, Non-Stem Cell, Bone Marrow, Blood and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: Cell Therapy Market in Asia Pacific is expected to register a CAGR of 28.6% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fujifilm Holdings Corporation, Smith & Nephew PLC, Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Medipost Co., Ltd., Stemedica Cell Technologies, Inc., NuVasive, Inc., Avantor, Inc., Vericel Corporation, and Pharmicell Co., Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Therapy Type
By Therapeutic Area
- Malignancies
- Autoimmune Disorders
- Musculoskeletal Disorders
- Dermatology
- Others
By End User
- Academic & Research Institutes
- Hospitals & Clinics
By Cell Type
- Stem Cell
- Umbilical Cord-Derived
- Adipose-Derived Stem Cell
- Non-Stem Cell
- Bone Marrow
- Blood
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Fujifilm Holdings Corporation
- Smith & Nephew PLC
- Kolon TissueGene, Inc.
- JCR Pharmaceuticals Co., Ltd.
- Medipost Co., Ltd.
- Stemedica Cell Technologies, Inc.
- NuVasive, Inc.
- Avantor, Inc.
- Vericel Corporation
- Pharmicell Co., Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Cell Therapy Market, by Therapy Type
1.4.2 Asia Pacific Cell Therapy Market, by Therapeutic Area
1.4.3 Asia Pacific Cell Therapy Market, by End User
1.4.4 Asia Pacific Cell Therapy Market, by Cell Type
1.4.5 Asia Pacific Cell Therapy Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Approvals & Trials
3.2.5 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
Chapter 4. Asia Pacific Cell Therapy Market by Therapy Type
4.1 Asia Pacific Autologous Market by Country
4.2 Asia Pacific Allogeneic Market by Country
Chapter 5. Asia Pacific Cell Therapy Market by Therapeutic Area
5.1 Asia Pacific Malignancies Market by Country
5.2 Asia Pacific Autoimmune Disorders Market by Country
5.3 Asia Pacific Musculoskeletal Disorders Market by Country
5.4 Asia Pacific Dermatology Market by Country
5.5 Asia Pacific Other Therapeutic Area Market by Country
Chapter 6. Asia Pacific Cell Therapy Market by End User
6.1 Asia Pacific Academic & Research Institutes Market by Country
6.2 Asia Pacific Hospitals & Clinics Market by Country
Chapter 7. Asia Pacific Cell Therapy Market by Cell Type
7.1 Asia Pacific Stem Cell Market by Country
7.2 Asia Pacific Umbilical Cord-Derived Cell Market by Country
7.3 Asia Pacific Adipose-Derived Stem Cell Market by Country
7.4 Asia Pacific Non-Stem Cell Market by Country
7.5 Asia Pacific Bone Marrow Cell Market by Country
7.6 Asia Pacific Blood Cell Market by Country
7.7 Asia Pacific Others Cell Market by Country
Chapter 8. Asia Pacific Cell Therapy Market by Country
8.1 China Cell Therapy Market
8.1.1 China Cell Therapy Market by Therapy Type
8.1.2 China Cell Therapy Market by Therapeutic Area
8.1.3 China Cell Therapy Market by End User
8.1.4 China Cell Therapy Market by Cell Type
8.2 Japan Cell Therapy Market
8.2.1 Japan Cell Therapy Market by Therapy Type
8.2.2 Japan Cell Therapy Market by Therapeutic Area
8.2.3 Japan Cell Therapy Market by End User
8.2.4 Japan Cell Therapy Market by Cell Type
8.3 India Cell Therapy Market
8.3.1 India Cell Therapy Market by Therapy Type
8.3.2 India Cell Therapy Market by Therapeutic Area
8.3.3 India Cell Therapy Market by End User
8.3.4 India Cell Therapy Market by Cell Type
8.4 South Korea Cell Therapy Market
8.4.1 South Korea Cell Therapy Market by Therapy Type
8.4.2 South Korea Cell Therapy Market by Therapeutic Area
8.4.3 South Korea Cell Therapy Market by End User
8.4.4 South Korea Cell Therapy Market by Cell Type
8.5 Singapore Cell Therapy Market
8.5.1 Singapore Cell Therapy Market by Therapy Type
8.5.2 Singapore Cell Therapy Market by Therapeutic Area
8.5.3 Singapore Cell Therapy Market by End User
8.5.4 Singapore Cell Therapy Market by Cell Type
8.6 Malaysia Cell Therapy Market
8.6.1 Malaysia Cell Therapy Market by Therapy Type
8.6.2 Malaysia Cell Therapy Market by Therapeutic Area
8.6.3 Malaysia Cell Therapy Market by End User
8.6.4 Malaysia Cell Therapy Market by Cell Type
8.7 Rest of Asia Pacific Cell Therapy Market
8.7.1 Rest of Asia Pacific Cell Therapy Market by Therapy Type
8.7.2 Rest of Asia Pacific Cell Therapy Market by Therapeutic Area
8.7.3 Rest of Asia Pacific Cell Therapy Market by End User
8.7.4 Rest of Asia Pacific Cell Therapy Market by Cell Type
Chapter 9. Company Profiles
9.1 Fujifilm Holdings Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Geographical Expansions:
9.2 Smith & Nephew PLC
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.5.2 Acquisition and Mergers:
9.3 Kolon TissueGene, Inc.
9.3.1 Company Overview
9.3.2 Recent strategies and developments:
9.3.2.1 Approvals & Trials:
9.4 JCR Pharmaceuticals Co., Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Research & Development Expense
9.4.4 Recent strategies and developments:
9.4.4.1 Partnerships, Collaborations, and Agreements:
9.4.4.2 Acquisition and Mergers:
9.4.4.3 Approvals & Trials:
9.5 Medipost Co., Ltd.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Recent strategies and developments:
9.5.3.1 Partnerships, Collaborations, and Agreements:
9.5.3.2 Approvals & Trials:
9.6 Stemedica Cell Technologies, Inc.
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Approvals & Trials:
9.7 NuVasive, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.8 Avantor, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Product Launches and Product Expansions:
9.8.4.2 Geographical Expansions:
9.9 Vericel Corporation
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Research & Development Expense
9.9.4 Recent strategies and developments:
9.9.4.1 Partnerships, Collaborations, and Agreements:
9.9.4.2 Product Launches and Product Expansions:
9.10. Pharmicell Co., Ltd.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Research & Development Expense
9.10.4 Recent strategies and developments:
9.10.4.1 Partnerships, Collaborations, and Agreements:
TABLE 1 Asia Pacific Cell Therapy Market, 2016 - 2019, USD Million
TABLE 2 Asia Pacific Cell Therapy Market, 2020 - 2026, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Cell Therapy Market
TABLE 4 Product Launches And Product Expansions– Cell Therapy Market
TABLE 5 Geographical Expansions– Cell Therapy Market
TABLE 6 Approvals & Trials– Cell Therapy Market
TABLE 7 Acquisition and Mergers– Cell Therapy Market
TABLE 8 Asia Pacific Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 9 Asia Pacific Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 10 Asia Pacific Autologous Market by Country, 2016 - 2019, USD Million
TABLE 11 Asia Pacific Autologous Market by Country, 2020 - 2026, USD Million
TABLE 12 Asia Pacific Allogeneic Market by Country, 2016 - 2019, USD Million
TABLE 13 Asia Pacific Allogeneic Market by Country, 2020 - 2026, USD Million
TABLE 14 Asia Pacific Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 15 Asia Pacific Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 16 Asia Pacific Malignancies Market by Country, 2016 - 2019, USD Million
TABLE 17 Asia Pacific Malignancies Market by Country, 2020 - 2026, USD Million
TABLE 18 Asia Pacific Autoimmune Disorders Market by Country, 2016 - 2019, USD Million
TABLE 19 Asia Pacific Autoimmune Disorders Market by Country, 2020 - 2026, USD Million
TABLE 20 Asia Pacific Musculoskeletal Disorders Market by Country, 2016 - 2019, USD Million
TABLE 21 Asia Pacific Musculoskeletal Disorders Market by Country, 2020 - 2026, USD Million
TABLE 22 Asia Pacific Dermatology Market by Country, 2016 - 2019, USD Million
TABLE 23 Asia Pacific Dermatology Market by Country, 2020 - 2026, USD Million
TABLE 24 Asia Pacific Other Therapeutic Area Market by Country, 2016 - 2019, USD Million
TABLE 25 Asia Pacific Other Therapeutic Area Market by Country, 2020 - 2026, USD Million
TABLE 26 Asia Pacific Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 27 Asia Pacific Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 28 Asia Pacific Academic & Research Institutes Market by Country, 2016 - 2019, USD Million
TABLE 29 Asia Pacific Academic & Research Institutes Market by Country, 2020 - 2026, USD Million
TABLE 30 Asia Pacific Hospitals & Clinics Market by Country, 2016 - 2019, USD Million
TABLE 31 Asia Pacific Hospitals & Clinics Market by Country, 2020 - 2026, USD Million
TABLE 32 Asia Pacific Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 33 Asia Pacific Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 34 Asia Pacific Stem Cell Market by Country, 2016 - 2019, USD Million
TABLE 35 Asia Pacific Stem Cell Market by Country, 2020 - 2026, USD Million
TABLE 36 Asia Pacific Umbilical Cord-Derived Cell Market by Country, 2016 - 2019, USD Million
TABLE 37 Asia Pacific Umbilical Cord-Derived Cell Market by Country, 2020 - 2026, USD Million
TABLE 38 Asia Pacific Adipose-Derived Stem Cell Market by Country, 2016 - 2019, USD Million
TABLE 39 Asia Pacific Adipose-Derived Stem Cell Market by Country, 2020 - 2026, USD Million
TABLE 40 Asia Pacific Non-Stem Cell Market by Country, 2016 - 2019, USD Million
TABLE 41 Asia Pacific Non-Stem Cell Market by Country, 2020 - 2026, USD Million
TABLE 42 Asia Pacific Bone Marrow Cell Market by Country, 2016 - 2019, USD Million
TABLE 43 Asia Pacific Bone Marrow Cell Market by Country, 2020 - 2026, USD Million
TABLE 44 Asia Pacific Blood Cell Market by Country, 2016 - 2019, USD Million
TABLE 45 Asia Pacific Blood Cell Market by Country, 2020 - 2026, USD Million
TABLE 46 Asia Pacific Others Cell Market by Country, 2016 - 2019, USD Million
TABLE 47 Asia Pacific Others Cell Market by Country, 2020 - 2026, USD Million
TABLE 48 Asia Pacific Cell Therapy Market by Country, 2016 - 2019, USD Million
TABLE 49 Asia Pacific Cell Therapy Market by Country, 2020 - 2026, USD Million
TABLE 50 China Cell Therapy Market, 2016 - 2019, USD Million
TABLE 51 China Cell Therapy Market, 2020 - 2026, USD Million
TABLE 52 China Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 53 China Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 54 China Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 55 China Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 56 China Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 57 China Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 58 China Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 59 China Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 60 Japan Cell Therapy Market, 2016 - 2019, USD Million
TABLE 61 Japan Cell Therapy Market, 2020 - 2026, USD Million
TABLE 62 Japan Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 63 Japan Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 64 Japan Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 65 Japan Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 66 Japan Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 67 Japan Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 68 Japan Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 69 Japan Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 70 India Cell Therapy Market, 2016 - 2019, USD Million
TABLE 71 India Cell Therapy Market, 2020 - 2026, USD Million
TABLE 72 India Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 73 India Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 74 India Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 75 India Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 76 India Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 77 India Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 78 India Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 79 India Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 80 South Korea Cell Therapy Market, 2016 - 2019, USD Million
TABLE 81 South Korea Cell Therapy Market, 2020 - 2026, USD Million
TABLE 82 South Korea Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 83 South Korea Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 84 South Korea Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 85 South Korea Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 86 South Korea Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 87 South Korea Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 88 South Korea Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 89 South Korea Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 90 Singapore Cell Therapy Market, 2016 - 2019, USD Million
TABLE 91 Singapore Cell Therapy Market, 2020 - 2026, USD Million
TABLE 92 Singapore Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 93 Singapore Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 94 Singapore Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 95 Singapore Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 96 Singapore Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 97 Singapore Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 98 Singapore Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 99 Singapore Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 100 Malaysia Cell Therapy Market, 2016 - 2019, USD Million
TABLE 101 Malaysia Cell Therapy Market, 2020 - 2026, USD Million
TABLE 102 Malaysia Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 103 Malaysia Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 104 Malaysia Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 105 Malaysia Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 106 Malaysia Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 107 Malaysia Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 108 Malaysia Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 109 Malaysia Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 110 Rest of Asia Pacific Cell Therapy Market, 2016 - 2019, USD Million
TABLE 111 Rest of Asia Pacific Cell Therapy Market, 2020 - 2026, USD Million
TABLE 112 Rest of Asia Pacific Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 113 Rest of Asia Pacific Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 114 Rest of Asia Pacific Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 115 Rest of Asia Pacific Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 116 Rest of Asia Pacific Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 117 Rest of Asia Pacific Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 118 Rest of Asia Pacific Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 119 Rest of Asia Pacific Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 120 Key Information – Fujifilm Holdings Corporation
TABLE 121 key Information – Smith & Nephew PLC
TABLE 122 key information – Kolon TissueGene, Inc.
TABLE 123 Key Information – JCR Pharmaceuticals Co., Ltd.
TABLE 124 Key Information – Medipost Co., Ltd.
TABLE 125 key Information – Stemedica Cell Technologies, Inc.
TABLE 126 Key Information – NuVasive, Inc.
TABLE 127 key information – Avantor, Inc.
TABLE 128 Key Information – Vericel Corporation
TABLE 129 Key Information – Pharmicell Co., Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Recent strategies and developments: Fujifilm Holdings Corporation
FIG 5 Recent strategies and developments: Smith & Nephew PLC
FIG 6 Recent strategies and developments: JCR Pharmaceuticals Co., Ltd.
FIG 7 Recent strategies and developments: Avantor, Inc.
FIG 8 Recent strategies and developments: Vericel Corporation